Card image cap

Michael Burgess' Public Statements on Issue: Drugs

Office:

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 6
Date Title
03/11/2022 Letter to Hon. Joseph R. Biden, President of the United States - Guthrie Leads Letter Criticizing President Biden's Misguided Approach to Addressing Deadly Fentanyl
02/14/2022 Letter to Hon. Joseph Biden, President of the United States of America - CONGRESSMAN VALADAO URGES BIDEN TO TAKE ACTION TO COMBAT FENTANYL EPIDEMIC
02/11/2022 Letter to Joseph R. Biden, President of the United States - Joyce Urges the President to Address Threat of Fentanyl-Related Substances Flooding into American Communities
01/13/2022 Helsinki Commission Welcomes First Charges Under The Rodchenkov Anti-Doping Act
04/21/2021 Burgess supports DEA Emergency Scheduling
04/14/2021 Providing for Consideration of H.R. Paycheck Fairness Act, and Providing for Consideration of H.R. Workplace Violence Prevention for Health Care and Social Service Workers Act
11/17/2020 Burgess reacts to RADA passing the Senate
10/23/2020 Letter to Timothy Shea, Acting Administrator of the Drug Enforcement Administration - E&C GOP Leaders Question DEA on Opioid Supply Management
10/23/2020 Walden & Burgess on Anniversary of Landmark Legislation: Now is Not the Time to Let Our Foot Off the Gas
08/11/2020 Letter to the Hon. Alex Azar, Secretary of the Dept. of Health and Human Services - Bipartisan Committee Leaders Request Information on COVID-19's Impact on Addiction & Overdose Crisis
03/03/2020 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Burgess, Hearing on Combating an Epidemic: Legislation to Help Patients with Substance Use Disorders
01/29/2020 Hearing of the Health subcommittee of the House Ways and Means Committee - Burgess Participates in a hearing concerning FDA legislation
01/23/2020 Letter to Gene Dodaro, Comptroller General of the Government Accountability Office - Republicans Request GAO to Review Grant Funding to Combat Opioid Crisis
01/14/2020 Lawmakers Raise Concerns Over Increased Use of Cocaine and Methamphetamine
10/29/2019 Burgess, Eshoo introduce Ready Reserve Legislation
10/22/2019 Rodchenkov Anti-Doping Act of 2019
10/22/2019 Corporate Transparency Act of 2019
10/16/2019 Burgess Statement on the House Committee on the Judiciary Voting to Pass the Rodchenkov Anti-Doping Act
09/18/2019 Letter to the Hon. Ron DeSantis, Governor of Florida, the Hon. Eric Holcomb, Governor of Indiana, the Hon. Matt Bevin, Governor of Kentucky, the Hon. Janet Mills, Governor of Maine, the Hon. Larry Hogan, Governor of Maryland, the Hon. Charlie Baker, Governor of Massachusetts, Michelle Lujan Grisham, Governor of New Mexico, the Hon. Andrew Cuomo, Governor of New York, the Hon. Roy Cooper, Governor of North Carolina, the Hon. Mike DeWine, Governor of Ohio, the Hon. Kate Brown, Governor of Oregon, the Hon. Tom Wolf, Governor of Pennsylvania, the Hon. Gina Raimondo, Governor of Rhode Island, the Hon. Bill Lee, Governor of Tennessee, the Hon. Jim Justice, Governor of West Virginia, and the Hon. Tony Evers, Governor of Wisconsin - E&C bipartisan leaders seek information from states on use of federal funds to respond to opioid crisis
08/28/2019 Letter to the Hon. Brett Giroir, U.S. Dept. of Health and Human Service's Assistant Secretary for Health - Brett E&C Republicans Press HHS for Update on SUPPORT Act Implementation
08/22/2019 Walden and Burgess Welcome Trump Administration's Partnership in Reforming SUD Confidentiality Law
06/25/2019 Letter to the Hon. Norma Sharpless, Acting Commissioner of the Food and Drug Administration - Bipartisan E&C Leaders Request FDA Briefing on Opioids
06/13/2019 Letter to Various Federal Agencies - Bipartisan E&C Leaders Request Briefings on Ongoing Threat Posed by Fentanyl from Six Federal Agencies
06/13/2019 Letter to the Hon. Kevin McAleenan, James Carroll, Utlam Dhillon, Megan Brennan, Michael Pompeo, and Norman Sharpless - Bipartisan E&C Leaders Request Briefings on Ongoing Threat Posed by Fentanyl From Six Federal Agencies
05/10/2019 Letter to the Hon. Norma Sharpless, Acting Commissioner of the Food and Drug Administration - Reps. Burgess and Roby Urge Continued FDA Oversight of Mail-Order Abortion Drugs
Page 1 of 6
arrow_upward